...
首页> 外文期刊>Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer >P2.01-022 Nintedanib/Docetaxel Efficacy in Advanced Lung Adenocarcinoma Treated with 1L Chemotherapy/2L Immunotherapy in Nintedanib NPU
【24h】

P2.01-022 Nintedanib/Docetaxel Efficacy in Advanced Lung Adenocarcinoma Treated with 1L Chemotherapy/2L Immunotherapy in Nintedanib NPU

机译:P2.01-022 Nintedanib / Docetaxel在Nintedanib NPU的1L化疗/ 2L免疫疗法治疗晚期肺腺癌中的疗效

获取原文
获取原文并翻译 | 示例
           

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号